Cargando…
Imaging-Based Machine Learning Analysis of Patient-Derived Tumor Organoid Drug Response
Three-quarters of compounds that enter clinical trials fail to make it to market due to safety or efficacy concerns. This statistic strongly suggests a need for better screening methods that result in improved translatability of compounds during the preclinical testing period. Patient-derived organo...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724556/ https://www.ncbi.nlm.nih.gov/pubmed/34993134 http://dx.doi.org/10.3389/fonc.2021.771173 |